New Federal Common Disclosure Forms Strengthen Integrity and Security of NIH-Funded Research

September 17, 2024

These Common Disclosure Forms for the Biographical Sketch and Current and Pending (Other) Support aim to standardize disclosure requirements and processes across federal research agencies, with the goal of reducing the time and effort researchers spend providing disclosure information to federal funders and ensuring integrity throughout the research process.

New Decision Matrix Further Clarifies NIH Processes for Handling Allegations of Foreign Interference

August 15, 2024

Today NIH issued a decision matrix for assessing potential foreign interference as part of its ongoing efforts to be transparent about its policies and procedures. The decision matrix builds on the detailed information already available on our site and also offers additional detail as to how NIH considers whether to contact institutions to request additional information.

Safeguarding Integrity and Collaborations: Not “Either-Or” but “Both-And”

May 25, 2023

Today Science published our letter “Safeguarding integrity and collaborations,” which summarizes our perspectives on NIH efforts to address long-standing foreign interference threats, many stemming from foreign malign talent recruitment programs. We are grateful to Science for publishing our letter and for endorsing our efforts to “talk more openly.”

Addressing Foreign Interference and Associated Risks to the Integrity of Biomedical Research, and How You Can Help

July 8, 2020

On Tuesday, June 23, Dr. Kelvin Drogemeier, the Director of the Office of Science and Technology Policy (OSTP), gave a presentation to the Federal Demonstration Partnership (FDP) on “Enhancing the Security and Integrity of America’s Research Enterprise.” Dr. Drogemeier articulated five “key takeaway” messages. I’d like to take this opportunity to summarize Dr. Drogemeier’s presentation and how it fits within the context of NIH extramural research.